Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence

by Meir Schechter, Cheli Melzer-Cohen, Aliza Rozenberg, Ilan Yanuv, Gabriel Chodick, Avraham Karasik, Mikhail Kosiborod, Ofri Mosenzon
Published 2021-08-01

From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes

by Ofri Mosenzon, Stefano Del Prato, Meir Schechter, Lawrence A. Leiter, Antonio Ceriello, Ralph A. DeFronzo, Itamar Raz
Published 2021-04-01

Proximal Tubule mTORC1 Is a Central Player in the Pathophysiology of Diabetic Nephropathy and Its Correction by SGLT2 Inhibitors

by Aviram Kogot-Levin, Liad Hinden, Yael Riahi, Tal Israeli, Boaz Tirosh, Erol Cerasi, Ernesto Bernal Mizrachi, Joseph Tam, Ofri Mosenzon, Gil Leibowitz
Published 2020-07-01

Adolescent cognitive function and incident early-onset type 2 diabetes

by Miri Lutski, Inbar Zucker, Aya Bardugo, Cole D. Bendor, Estela Derazne, Dorit Tzur, Deborah Novick, Itamar Raz, Orit Pinhas-Hamiel, Ofri Mosenzon, Arnon Afek, Hertzel C. Gerstein, Gilad Twig, Tali Cukierman-Yaffe
Published 2021-11-01

Adolescent BMI and early-onset type 2 diabetes among Ethiopian immigrants and their descendants: a nationwide study

by Maya Simchoni, Uri Hamiel, Orit Pinhas-Hamiel, Inbar Zucker, Tali Cukierman-Yaffe, Miri Lutski, Estela Derazne, Zivan Beer, Doron Behar, Lital Keinan-Boker, Ofri Mosenzon, Dorit Tzur, Arnon Afek, Amir Tirosh, Itamar Raz, Gilad Twig
Published 2020-10-01

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

by Ofri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, Fahri Bayram, Patrice Darmon, Timothy M. E. Davis, Guillermo Dieuzeide, Kirsten T. Eriksen, Tianpei Hong, Margit S. Kaltoft, Csaba Lengyel, Nicolai A. Rhee, Giuseppina T. Russo, Shinichiro Shirabe, Katerina Urbancova, Sergio Vencio, the CAPTURE Study Investigators
Published 2021-07-01